12172 related articles for article (PubMed ID: 11876547)
1. Detection of tyrosinase mRNA by an optimised nested RT-PCR in the peripheral blood of patients with advanced malignant melanoma.
Glumac N; Hocevar M; Snoj M; Novakovic S
J Exp Clin Cancer Res; 2001 Dec; 20(4):529-36. PubMed ID: 11876547
[TBL] [Abstract][Full Text] [Related]
2. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
3. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
4. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
[TBL] [Abstract][Full Text] [Related]
5. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.
Ghossein RA; Coit D; Brennan M; Zhang ZF; Wang Y; Bhattacharya S; Houghton A; Rosai J
Clin Cancer Res; 1998 Feb; 4(2):419-28. PubMed ID: 9516931
[TBL] [Abstract][Full Text] [Related]
8. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.
Glumac N; Snoj M; Hocevar M; Novakovic S
Neoplasma; 2006; 53(1):9-14. PubMed ID: 16416006
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
[TBL] [Abstract][Full Text] [Related]
11. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
[TBL] [Abstract][Full Text] [Related]
13. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
14. Tumour microdissemination and survival in metastatic melanoma.
Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Franzke A; Sel S; Atzpodien E; Buer J
Anticancer Res; 2000; 20(5B):3619-24. PubMed ID: 11131671
[TBL] [Abstract][Full Text] [Related]
15. Comparison between three molecular methods for detection of blood melanoma tyrosinase mRNA. Correlation with melanoma stages and S100B, LDH, NSE biochemical markers.
Santonocito C; Concolino P; Lavieri MM; Ameglio F; Gentileschi S; Capizzi R; Rocchetti S; Amerio P; Castagnola M; Zuppi C; Capoluongo E
Clin Chim Acta; 2005 Dec; 362(1-2):85-93. PubMed ID: 16054123
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
18. Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes.
Calogero A; Timmer-Bosscha H; Schraffordt Koops H; Tiebosch AT; Mulder NH; Hospers GA
Br J Cancer; 2000 Jul; 83(2):184-7. PubMed ID: 10901368
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
Tsao H; Nadiminti U; Sober AJ; Bigby M
Arch Dermatol; 2001 Mar; 137(3):325-30. PubMed ID: 11255333
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
